257 related articles for article (PubMed ID: 34431086)
1. The multidimensional role of the Wnt/β-catenin signaling pathway in human malignancies.
Hiremath IS; Goel A; Warrier S; Kumar AP; Sethi G; Garg M
J Cell Physiol; 2022 Jan; 237(1):199-238. PubMed ID: 34431086
[TBL] [Abstract][Full Text] [Related]
2. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
Dzobo K; Thomford NE; Senthebane DA
OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
Lee SK; Hwang JH; Choi KY
Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
[TBL] [Abstract][Full Text] [Related]
5. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.
Castiglia D; Bernardini S; Alvino E; Pagani E; De Luca N; Falcinelli S; Pacchiarotti A; Bonmassar E; Zambruno G; D'Atri S
Genes Chromosomes Cancer; 2008 Jul; 47(7):614-24. PubMed ID: 18384130
[TBL] [Abstract][Full Text] [Related]
6. Genomic insights into WNT/β-catenin signaling.
Rosenbluh J; Wang X; Hahn WC
Trends Pharmacol Sci; 2014 Feb; 35(2):103-9. PubMed ID: 24365576
[TBL] [Abstract][Full Text] [Related]
7. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.
White BD; Chien AJ; Dawson DW
Gastroenterology; 2012 Feb; 142(2):219-32. PubMed ID: 22155636
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors.
Krishnamurthy N; Kurzrock R
Cancer Treat Rev; 2018 Jan; 62():50-60. PubMed ID: 29169144
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
Katoh M; Katoh M
Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
[TBL] [Abstract][Full Text] [Related]
11. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
12. Ginkgolide C promotes apoptosis and abrogates metastasis of colorectal carcinoma cells by targeting Wnt/β-catenin signaling pathway.
Yang MH; Ha IJ; Lee SG; Lee J; Um JY; Ahn KS
IUBMB Life; 2021 Oct; 73(10):1222-1234. PubMed ID: 34273236
[TBL] [Abstract][Full Text] [Related]
13. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
[No Abstract] [Full Text] [Related]
14. Wnt/β-catenin Signaling Inhibitors.
Zhang X; Dong N; Hu X
Curr Top Med Chem; 2023; 23(10):880-896. PubMed ID: 36872364
[TBL] [Abstract][Full Text] [Related]
15. Role of m
Tabnak P; Ghasemi Y; Natami M; Khorram R; Ebrahimnezhad M
Biomed Pharmacother; 2023 Jan; 157():114023. PubMed ID: 36403567
[TBL] [Abstract][Full Text] [Related]
16. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling.
Scholer-Dahirel A; Schlabach MR; Loo A; Bagdasarian L; Meyer R; Guo R; Woolfenden S; Yu KK; Markovits J; Killary K; Sonkin D; Yao YM; Warmuth M; Sellers WR; Schlegel R; Stegmeier F; Mosher RE; McLaughlin ME
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17135-40. PubMed ID: 21949247
[TBL] [Abstract][Full Text] [Related]
18. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
19. A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis.
Fang L; Zhu Q; Neuenschwander M; Specker E; Wulf-Goldenberg A; Weis WI; von Kries JP; Birchmeier W
Cancer Res; 2016 Feb; 76(4):891-901. PubMed ID: 26645562
[TBL] [Abstract][Full Text] [Related]
20. The roles of Wnt/β-catenin pathway in tissue development and regenerative medicine.
Majidinia M; Aghazadeh J; Jahanban-Esfahlani R; Yousefi B
J Cell Physiol; 2018 Aug; 233(8):5598-5612. PubMed ID: 29150936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]